Skip to main content
. 2021 Jan 23;29(8):4595–4605. doi: 10.1007/s00520-021-06002-5

Table 3.

Baseline physiological measures

Outcome Exercise group Usual care
Mean ± SD Mean ± SD
Flow-mediated dilatation
  Baseline diameter (mm) 4.8 ± 0.6 4.8 ± 0.5
  Max diameter (mm) 5.2 ± 0.9 5.1 ± 0.8
  Recovery diameter (mm) 5.0 ± 0.6 5.1 ± 0.4
  FMD (%) 6.9 ± 2.4 7.6 ± 2.4
  Shear baseline (s−1) 76.8 ± 24.5 80.9 ± 20.8
  Shear max (s−1) 390.8 ± 76.0 389.8 ± 143.3
  Shear area to max 8558.9 ± 1638.5 8883.6 ± 4413.4
Cardiovascular health
  Resting heart rate (bpm) 71.7 ± 12.5 66.8 ± 9.3
  SBP (mmHg) 138 ± 17 136 ± 15
  DBP (mmHg) 82 ± 13 82 ± 9
  QRisk-2 Score (%) 17.0 ± 7.7 18.0 ± 6.8
Anthropometric profile
  Body mass (kg) 88.0 ± 13.3 87.6 ± 13.9
  Body mass index (kg/m2) 28.1 ± 3.5 28.3 ± 4.1
  Waist circumference (cm) 99.6 ± 10.0 103.0 ± 9.7
  Waist/hip 1.0 ± 0.1 1.0 ± 0.1
  Fat (%) 18.3 ± 4.0 17.9 ± 4.6
  Sum of 6 skinfolds (mm) 104 ± 25 101 ± 27
  Sum of 8 skinfolds (mm) 136 ± 29 133 ± 35
Blood biomarkers
  Glucose (mmol/L) 6.2 ± 1.9 5.4 ± 0.6
  Insulin (μU/ml) 34.2 ± 14.7 38.4 ± 21.5
  HOMA-IR 2.3 ± 5.4 0.6 ± 0.4
  Total Chol (mmol/L) 5.0 ± 1.1 5.0 ± 1.5
  HDL (mmol/L) 1.3 ± 0.3 1.3 ± 0.3
  LDL (mmol/L) 3.2 ± 0.8 2.8 ± 1.2
  Non-HDL (mmol/L) 3.7 ± 1.0 3.8 ± 1.5
  Triglycerides (mmol/L) 1.5 ± 0.7 1.4 ± 0.6
  Total/HDL (mmol/L) 4.0 ± 0.9 4.0 ± 1.1
Submaximal aerobic exercise
  Stage 30.0 ± 11.4 29.8 ± 10.3
  Time (secs) 580 ± 229 576 ± 205
  Estimated VO2Peak (ml/kg/min) 38.6 ± 13.8 38.7 ± 12.5
  Max heart rate (bpm) 143.2 ± 17.3 132.9 ± 17.3
Strength
  30-s bicep curl test (reps) 20.0 ± 5.7 19.4 ± 4.2
  30-s chair stand test (reps) 17.9 ± 5.1 16.1 ± 5.3

SD standard deviation, FMD flow-mediated dilatation, SBP systolic blood pressure, DBP diastolic blood pressure, HOMA-IR insulin resistance, Chol cholesterol, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, VO2Peak maximal aerobic capacity, reps repetitions, secs seconds